Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Efficacious immunomodulatory activity of the chemokine stromal cell–derived factor 1 (SDF-1): local secretion of SDF-1 at the tumor site serves as T-cell chemoattractant and mediates T-cell–dependent antitumor responses

Kyriaki Dunussi-Joannopoulos, Krystyna Zuberek, Kathlene Runyon, Robert G. Hawley, Anthony Wong, Jamie Erickson, Steve Herrmann, John P. Leonard

Blood (2002) 100 (5): 1551–1558.

https://doi.org/10.1182/blood.V100.5.1551.h81702001551_1551_1558

Published: 2002

Journal Articles

The combination of chemotherapy and systemic immunotherapy with soluble B7–immunoglobulin G leads to cure of murine leukemia and lymphoma and demonstration of tumor-specific memory responses

Kathlene Runyon, Kwang Lee, Krystyna Zuberek, Mary Collins, John P. Leonard, Kyriaki Dunussi-Joannopoulos

Blood (2001) 97 (8): 2420–2426.

https://doi.org/10.1182/blood.V97.8.2420

Published: 2001

Journal Articles

Vaccines With Interleukin-12–Transduced Acute Myeloid Leukemia Cells Elicit Very Potent Therapeutic and Long-Lasting Protective Immunity

Kyriaki Dunussi-Joannopoulos, Kathlene Runyon, Jamie Erickson, Robert G. Schaub, Robert G. Hawley, John P. Leonard

Blood (1999) 94 (12): 4263–4273.

https://doi.org/10.1182/blood.V94.12.4263

Published: 1999

Journal Articles

Gene Immunotherapy in Murine Acute Myeloid Leukemia: Granulocyte-Macrophage Colony-Stimulating Factor Tumor Cell Vaccines Elicit More Potent Antitumor Immunity Compared With B7 Family and Other Cytokine Vaccines

Kyriaki Dunussi-Joannopoulos, Glenn Dranoff, Howard J. Weinstein, James L.M. Ferrara, Barbara E. Bierer, James M. Croop

Blood (1998) 91 (1): 222–230.

https://doi.org/10.1182/blood.V91.1.222

Published: 1998

Journal Articles

CD8 + T Cells Activated During the Course of Murine Acute Myelogenous Leukemia Elicit Therapeutic Responses to Late B7 Vaccines After Cytoreductive Treatment

Kyriaki Dunussi-Joannopoulos, Werner Krenger, Howard J. Weinstein, James L.M. Ferrara, James M. Croop

Blood (1997) 89 (8): 2915–2924.

https://doi.org/10.1182/blood.V89.8.2915

Published: 1997

NARROW

Efficacious immunomodulatory activity of the chemokine stromal cell–derived factor 1 (SDF-1): local secretion of SDF-1 at the tumor site serves as T-cell chemoattractant and mediates T-cell–dependent antitumor responses

The combination of chemotherapy and systemic immunotherapy with soluble B7–immunoglobulin G leads to cure of murine leukemia and lymphoma and demonstration of tumor-specific memory responses

Vaccines With Interleukin-12–Transduced Acute Myeloid Leukemia Cells Elicit Very Potent Therapeutic and Long-Lasting Protective Immunity

Gene Immunotherapy in Murine Acute Myeloid Leukemia: Granulocyte-Macrophage Colony-Stimulating Factor Tumor Cell Vaccines Elicit More Potent Antitumor Immunity Compared With B7 Family and Other Cytokine Vaccines

CD8 + T Cells Activated During the Course of Murine Acute Myelogenous Leukemia Elicit Therapeutic Responses to Late B7 Vaccines After Cytoreductive Treatment

Email alerts

ASH Publications

American Society of Hematology

Efficacious immunomodulatory activity of the chemokine stromal cell–derived factor 1 (SDF-1): local secretion of SDF-1 at the tumor site serves as T-cell chemoattractant and mediates T-cell–dependent antitumor responses

The combination of chemotherapy and systemic immunotherapy with soluble B7–immunoglobulin G leads to cure of murine leukemia and lymphoma and demonstration of tumor-specific memory responses

Vaccines With Interleukin-12–Transduced Acute Myeloid Leukemia Cells Elicit Very Potent Therapeutic and Long-Lasting Protective Immunity

Gene Immunotherapy in Murine Acute Myeloid Leukemia: Granulocyte-Macrophage Colony-Stimulating Factor Tumor Cell Vaccines Elicit More Potent Antitumor Immunity Compared With B7 Family and Other Cytokine Vaccines

CD8 + T Cells Activated During the Course of Murine Acute Myelogenous Leukemia Elicit Therapeutic Responses to Late B7 Vaccines After Cytoreductive Treatment

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only